Canada-based MedReleaf Corp. is ranked as the world’s fourth-largest marijuana company with a market capitalization of $2.64 billion. The company has two ICH-GMP and ISO 9001 certified facilities in Ontario, with a third facility currently in development. In May, MedReleaf agreed to be acquired by larger Canadian peer Aurora Cannabis for C$3.2 billion.MedReleaf recently closed its previously-announced agreement to acquire 1 million square feet of existing greenhouse infrastructure on a 69 acre property in Exeter, Ontario and 95 acres of adjacent land. The Exeter facility will have annual production capacity of up to 105,000 kilograms, increasing MedReleaf's fully funded annual production capacity to 140,000 kilograms.